Skip to main content
Equibles

HSG Holding Ltd

Position in GPCR — Structure Therapeutics Inc.

CIK 1470766 NA, K3
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,279,547
+$1,455,359 QoQ
Shares Held
266,062
0.0% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#35
of 191 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSG Holding Ltd holds $70,756,776 across 6 Biotechnology names. GPCR ranks #3 (20.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GYRE
Gyre Therapeutics, Inc.
 3,750,299 $24,714,470
2 AVBP
ArriVent BioPharma, Inc.
 663,308 $23,043,319
3 GPCR
Structure Therapeutics Inc.
This page 		266,062 $14,279,547
4 ADAG
Adagene Inc.
 1,343,364 $5,642,128
5 LYEL
Lyell Immunopharma, Inc.
 152,299 $2,139,800
6 BRNS
Barinthus Biotherapeutics plc.
 1,420,473 $937,512

All Filings in GPCR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,279,547 266,062
2026-03-31 $12,824,188 266,062
2025-12-31 $18,504,611 266,062
2025-09-30 $7,449,736 266,062
2025-06-30 $5,518,125 266,062
2025-03-31 $4,605,532 266,062
2024-12-31 $7,215,601 266,062
2024-09-30 $11,677,460 266,062
2024-06-30 $10,448,254 266,062
2024-03-31 $45,645,128 1,064,982
2023-12-31 $43,418,611 1,065,226
2023-09-30 $53,708,694 1,065,226